BCPC | Ticker Profile - Titan Protect

BCPC

Balchem Corporation

Basic Materials · Specialty Chemicals · NMS

$159.91

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$5.2B

Total market value of the company

Trailing P/E

33.04

Premium valuation

Forward P/E

26.34

Based on estimated future earnings — lower means cheaper

Rev Growth

+8.1%

Year-over-year revenue change

Profit Margin

15.0%

How much profit the company keeps from each dollar of revenue

ROE

12.7%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$202.50

+27% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 4 analysts covering this stock

About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

https://www.balchem.com

Country: United States Employees: 1,368 Industry: Specialty Chemicals

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.291

Positive but modest risk-adjusted returns

Kelly Fraction

0.0211

Modest edge detected — smaller position warranted

Calmar Ratio

0.178

Drawdown risk outweighs the returns — higher risk profile

Annual Return

4.1%

Historical annualised return based on price data

Max Drawdown

-23.1%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.85

Less volatile than the market — more defensive

52W High

$183.90

13% below the year high

52W Low

$139.17

15% above the year low

Avg Volume

197,621

Average daily shares traded — higher means easier to buy and sell

Short Ratio

1.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

1.6%

Low short interest — limited bearish positioning

Div Yield

60.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$4.87

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

14.37

Heavy leverage — higher financial risk if revenues decline

Current Ratio

2.55

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

1.49

Like current ratio but excludes inventory — stricter test

Gross Margin

36.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

20.9%

Profit from core operations before interest and tax

Free Cash Flow

$138M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.1B

Total revenue over the last 12 months

Net Income

$158M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$234.00

Target Median

$202.50

Target Low

$164.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go